Home  >  News
Msc_Jun22 Advertisement
6Sugar_Free_Sweetener.gif
you can get e-magazine links on WhatsApp. Click here
Events + Font Resize -

Philip Kotler highlights need for human-to-human marketing for pharma industry at PharmaState Academy event

Our Bureau, Bengaluru
Wednesday, June 2, 2021, 15:40 Hrs  [IST]

Philip Kotler, the global leader of marketing management has highlighted the need for human-to-human marketing when the world is getting increasingly dominated by machines. The marketing management mentor focused on human integrity in marketing and how through marketing, could make the world a better place.

At a webucational programme organized by the PharmaState Academy an online learning & development platform for the lifesciences industry professionals brought together Kotler along with his co-authors Prof. Waldemar Pfoertsch and Prof. Uwe Sponholz led the discussions which went on for close to three hours.

The panel discussed on the book titled ‘H2H Marketing: The Genesis Of Human-To-Human Marketing’ where 6,000 people participated in the virtual event.

Prof Kotler strongly believed that pharma companies in India and the world over can and should use H2H marketing for the benefit of the patients, companies and every other stakeholder.

Further the authors along with the industry personnel Pranav Kumar, Prashant Menon and Salil Kallianpur conversed extensively on facets of Design Thinking, Service-Dominant Logic and Digitalization.

Vivek Hattangadi, chief mentor, The Enablers, noted that trust is the foundation for H2H Mindset and should begin at the top management cadre. H2H Marketing will surely disrupt pharma marketing practices. It seamlessly weaves into the patient-centric approach in pharma marketing, the marketing model of the 21st Century.

The programme was moderated by author and writer Gauri Chaudhari and hosted by Dr Swati Sinha, CEO, PharmaState Academy.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
truking"
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |